Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:43 p.m.

    📋 HARVARD BIOSCIENCE, INC. (HBIO) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:01:48

    Event Type: Financial Results

    Event Details:

    Harvard Bioscience Inc (HBIO) Reports Q3 2022 Financial Results Harvard Bioscience Inc (HBIO) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 11116
    • Net Income: 2435
    • EPS: $ 0.05
    • Cash and equivalents: 4259

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Revenue 29.20K 29.20K $0.00 +0.00%
    Other Expense Income Interest Expense 377.00 377.00 $0.00 +0.00%
    Liabilities And Stockholders Equity Other Long Term Liabilities 8.65K 8.65K $0.00 +0.00%
    Cash Flows From Operating Activities Net Loss 4.45K 4.45K $0.00 +0.00%
    Interest Expense 377.00 377.00 $0.00 +0.00%
    Net Loss 1.08K 1.08K $0.00 +0.00%
    Other Income, Net 16.00 16.00 $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Harvard Bioscience Inc
    • CIK: 0001123494
    • Ticker Symbol: HBIO
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories